7,862 Shares in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) Acquired by Flputnam Investment Management Co.

Flputnam Investment Management Co. bought a new stake in shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 7,862 shares of the company’s stock, valued at approximately $327,000. Flputnam Investment Management Co. owned about 0.15% of SPDR S&P Pharmaceuticals ETF at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Bank of America Corp DE lifted its position in SPDR S&P Pharmaceuticals ETF by 16.1% during the fourth quarter. Bank of America Corp DE now owns 323,407 shares of the company’s stock valued at $13,244,000 after purchasing an additional 44,871 shares during the period. LPL Financial LLC boosted its stake in shares of SPDR S&P Pharmaceuticals ETF by 26.4% in the 3rd quarter. LPL Financial LLC now owns 124,782 shares of the company’s stock worth $4,960,000 after buying an additional 26,031 shares during the last quarter. JPMorgan Chase & Co. grew its holdings in shares of SPDR S&P Pharmaceuticals ETF by 72.9% in the second quarter. JPMorgan Chase & Co. now owns 104,298 shares of the company’s stock worth $4,380,000 after acquiring an additional 43,959 shares during the period. Wells Fargo & Company MN increased its position in SPDR S&P Pharmaceuticals ETF by 30.0% during the fourth quarter. Wells Fargo & Company MN now owns 82,761 shares of the company’s stock valued at $3,389,000 after acquiring an additional 19,091 shares during the last quarter. Finally, First Citizens Bank & Trust Co. lifted its holdings in SPDR S&P Pharmaceuticals ETF by 1.3% in the third quarter. First Citizens Bank & Trust Co. now owns 58,439 shares of the company’s stock valued at $2,323,000 after acquiring an additional 748 shares during the period.

SPDR S&P Pharmaceuticals ETF Stock Performance

Shares of NYSEARCA:XPH opened at $39.10 on Friday. The stock’s 50-day simple moving average is $42.98 and its two-hundred day simple moving average is $40.55. The stock has a market capitalization of $191.59 million, a price-to-earnings ratio of 14.45 and a beta of 0.87. SPDR S&P Pharmaceuticals ETF has a 52-week low of $34.67 and a 52-week high of $45.62.

About SPDR S&P Pharmaceuticals ETF

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.